Obesity Trial, Recruiting NCT07406295 Sponsor: Florida State University Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07406295
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a Body Mass Index (BMI) of 30 or higher (a measure of body weight relative to height)
  • Women with a waist measurement of 88 cm or more, or men with a waist measurement of 102 cm or more

Who may not be able to join:

  • People whose body weight has changed by more than 5% in the past six months (i.e., weight has not been stable)
  • People with a known heart, neurological, kidney, liver, or metabolic condition (such as diabetes)
  • People with currently uncontrolled high blood pressure, specifically Stage 2 hypertension (blood pressure above 140/90 mmHg) — note that blood pressure medication is permitted
  • People diagnosed with obstructive sleep apnea (a sleep condition affecting breathing)
  • People who have previously had weight-loss (bariatric) surgery
  • People diagnosed with, or showing signs of, an airway or lung disease
  • People who currently use, or have regularly used in the past 6 months, tobacco or nicotine products such as cigarettes or vaping devices
  • Women who are pregnant, breastfeeding, or post-menopausal (all self-reported; pregnancy also confirmed by a urine test)
  • People who are currently incarcerated
  • People who have recently had abdominal surgery or have an abdominal hernia
  • People with asthma who have very low awareness of their own symptoms, frequent severe episodes, or an unusually low sense of breathlessness
  • People with a ruptured eardrum or other ear conditions
  • People with significantly elevated pressure or volume in the left side of the heart (confirm with trial site)
  • People whose heart failure symptoms have worsened during breathing training
  • People currently experiencing a cold, sinus infection, or respiratory tract infection

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Joseph C Watso, PhD, Florida State University

Phone: 9522121833

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida State University
Registry
ClinicalTrials.gov
Start date
27 January 2026
Est. completion
1 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in middle cerebral artery blood velocity reactivity to hypercapnia

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov